UK startup Clarity Sensors wins €2.2 million NIHR award to widen access to advanced medical imaging
Cambridge-based semiconductor startup Clarity Sensors has received a €2.2 million award from the UK's National Institute for Health and Care Research to develop photon-counting CT detectors. The aim is to make advanced imaging cheaper and more available to hospitals.
Clarity Sensors, a semiconductor startup based in Cambridge, UK, has secured €2.2 million to develop a new generation of photon-counting computed tomography (CT) detectors. The money comes as a Product Development Award from the National Institute for Health and Care Research (NIHR), under its Invention for Innovation programme. The goal is to make advanced medical imaging more affordable and accessible to hospitals.
Why it matters
Photon-counting CT measures the energy of individual X-ray photons to produce detailed images of tissues and materials. Compared with conventional CT, such systems have shown better image resolution and considerably lower radiation exposure in clinical use. That could matter most for children and for patients who need repeated scans, for example when being monitored for cancer or cardiovascular disease. Access is still largely limited to specialist centres, partly because the semiconductor materials are costly and complex to manufacture.
Current detectors rely on cadmium telluride and cadmium zinc telluride crystals, which can take months to grow at temperatures above 750 °C. Clarity Sensors, founded in 2022, is developing an alternative from halide perovskite single crystals that can be grown at about 40 °C in just a few days. The company says early laboratory tests show its sensors can already match existing cadmium telluride detectors on key measures and remain stable under X-ray conditions relevant to CT.
The PICASO project
The startup leads the three-year project, called PICASO, and receives €1.5 million (£1.3 million) of the total. The rest goes to the Technology Department of the Science and Technology Facilities Council (STFC). The project started on 1 October 2026 and runs until September 2029. Clarity Sensors will pair its sensors with the STFC's HEXITEC-MHz readout technology, a UK-developed X-ray imaging system that can operate at one million frames per second.
The company also plans pilot-scale sensor production at its Cambridge facility and quality management controls, to move from laboratory work towards quality-controlled manufacturing. The project will assess the economic and clinical implications of wider photon-counting CT use in the NHS, and includes patient involvement through an advisory group and two workshops with the NIHR Cambridge Biomedical Research Centre.
CEO Dr. Hayden Salway said the aim is to supply perovskite detector technology to CT manufacturers. If successful, the project could help bring the technology to district general hospitals and community diagnostic centres.


